Article

Evidence of long-lasting humoral and cellular immunity against SARS-CoV-2 even in elderly COVID-19 convalescents showing a mild to moderate disease progression

2021-02-24

Abstract excerpt

After the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in China in late 2019, a pandemic evolved that has claimed millions of lives so far. While about 80 % of infections cause mild or moderate COVID-19 disease, some individuals show a severe progression or even die. Most countries are far from achieving herd-immunity, however, the first approved vaccines offe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3b6a7506-69d6-5d79-a4bd-1c99e53d7f04
DOI: 10.1101/2021.02.23.21251891

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evidence of long-lasting humoral and cellular immunity against SARS-CoV-2 even in elderly COVID-19 convalescents showing a mild to moderate disease progressionDOI 10.1101/2021.02.23.21251891Read

Immunity to SARS-CoV-2 up to 15 months after infectionSemantic proximity Read

Changes of Humoral Immunity Response in SARS-CoV-2 Convalescent Patients over 8 monthsSemantic proximity Read

Clinical and Immunological Characteristics in COVID-19 Convalescent PatientsSemantic proximity Read

Persistent while declined neutralizing antibody responses in the convalescents of COVID-19 across clinical spectrum during the 16 months follow upSemantic proximity Read

Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescentsSemantic proximity Read

Immune Features of COVID-19 Convalescent Individuals Revealed by a Single-cell RNA SequencingSemantic proximity Read

Persistence of robust humoral immune response in COVID-19 convalescent individuals over 12 months after infectionSemantic proximity Read

Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during ConvalescenceSemantic proximity Read

Convalescent Adaptive Immunity is Highly Heterogenous after SARS-CoV-2 InfectionSemantic proximity Read

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19Semantic proximity Read

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19Semantic proximity Read

Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells.Semantic proximity Read